Protein 4.1B contributes to the organization of peripheral myelinated axons

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Cifuentes Diaz, Carmen ^a,b   Chareyre, Fabrice ^c,f   Garcia, Marta ^a,b   Devaux, Jérôme ^d   Carnaud, Michèle ^a,b   Levasseur, Grégoire ^a,b,g   Niwa Kawakita, Michiko ^c   Harroch, Sheila ^e   Girault, Jean Antoine ^a,b   Giovannini, Marco ^c,f   Goutebroze, Laurence ^a,b  

^a INSTITUT DU FER À MOULIN   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d University of Mediterranée   (France)

^e INSTITUT PASTEUR   (France)

^f HOUSE EAR INSTITUTE   (United States)

^g CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN 4.1B; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; EPB4.1L1 PROTEIN, RAT; EPB4.1L3 PROTEIN, MOUSE; ISOPROTEIN;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ELECTROPHYSIOLOGY; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; MOUSE; MYELINATED NERVE; MYELINATION; NERVE CONDUCTION; NERVE FIBER; NEUROFILAMENT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RANVIER NODE; REACTION TIME; SEQUENCE HOMOLOGY; ALTERNATIVE RNA SPLICING; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; ERYTHROCYTE; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; METHODOLOGY; MOUSE MUTANT; MUTATION; MYELIN SHEATH; NERVE CELL; RAT; SCIATIC NERVE; TEMPERATURE;

MUS;

ALTERNATIVE SPLICING; ANIMALS; AXONS; ELECTROPHYSIOLOGY; ERYTHROCYTES; FEMALE; MALE; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MUTATION; MYELIN SHEATH; NEURONS; PROTEIN ISOFORMS; RATS; SCIATIC NERVE; TEMPERATURE;

EID: 80053156917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025043     Document Type: Article

References (65)

1. Diakowski W, Grzybek M, Sikorski AF, (2006) Protein 4.1, a component of the erythrocyte membrane skeleton and its related homologue proteins forming the protein 4.1/FERM superfamily. Folia Histochem Cytobiol 44: 231-248.
2. Ni X, Ji C, Cao G, Cheng H, Guo L, et al. (2003) Molecular cloning and characterization of the protein 4.1O gene, a novel member of the protein 4.1 family with focal expression in ovary. J Hum Genet 48: 101-106.
3. Yamakawa H, Ohara R, Nakajima D, Nakayama M, Ohara O, (1999) Molecular characterization of a new member of the protein 4.1 family (brain 4.1) in rat brain. Brain Res Mol Brain Res 70: 197-209.
4. Parra M, Gascard P, Walensky LD, Gimm JA, Blackshaw S, et al. (2000) Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain. J Biol Chem 275: 3247-3255.
5. Tran YK, Bogler O, Gorse KM, Wieland I, Green MR, et al. (1999) A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res 59: 35-43.
6. Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, et al. (2000) Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 9: 1495-1500.
7. Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A, (2002) Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas. Mod Pathol 15: 526-531.
8. Charboneau AL, Singh V, Yu T, Newsham IF, (2002) Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells. Int J Cancer 100: 181-188.
9. Ohno N, Terada N, Murata S, Yamakawa H, Newsham IF, et al. (2004) Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium. Histochem Cell Biol 122: 579-586.
10. Wong SY, Haack H, Kissil JL, Barry M, Bronson RT, et al. (2007) Protein 4.1B suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci U S A 104: 12784-12789.
11. Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, et al. (2007) Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat 103: 283-291.
12. Salzer JL, Brophy PJ, Peles E, (2008) Molecular domains of myelinated axons in the peripheral nervous system. Glia 56: 1532-1540.
13. Susuki K, Rasband MN, (2008) Molecular mechanisms of node of Ranvier formation. Curr Opin Cell Biol 20: 616-623.
14. Ohara R, Yamakawa H, Nakayama M, Ohara O, (2000) Type II brain 4.1 (4.1B/KIAA0987), a member of the protein 4.1 family, is localized to neuronal paranodes. Brain Res Mol Brain Res 85: 41-52.
15. Denisenko-Nehrbass N, Oguievetskaia K, Goutebroze L, Galvez T, Yamakawa H, et al. (2003) Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres. Eur J Neurosci 17: 411-416.
16. Ogawa Y, Schafer DP, Horresh I, Bar V, Hales K, et al. (2006) Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. J Neurosci 26: 5230-5239.
17. Horresh I, Bar V, Kissil JL, Peles E, (2010) Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B. J Neurosci 30: 2480-2489.
18. Buttermore ED, Dupree JL, Cheng J, An X, Tessarollo L, et al. (2011) The cytoskeletal adaptor protein band 4.1B is required for the maintenance of paranodal axoglial septate junctions in myelinated axons. J Neurosci 31: 8013-8024.
19. Poliak S, Gollan L, Salomon D, Berglund EO, Ohara R, et al. (2001) Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon. J Neurosci 21: 7568-7575.
20. Girault JA, Labesse G, Mornon JP, Callebaut I, (1998) Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction. Mol Med 4: 751-769.
21. Gollan L, Sabanay H, Poliak S, Berglund EO, Ranscht B, et al. (2002) Retention of a cell adhesion complex at the paranodal junction requires the cytoplasmic region of Caspr. J Cell Biol 157: 1247-1256.
22. Traka M, Goutebroze L, Denisenko N, Bessa M, Nifli A, et al. (2003) Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 162: 1161-1172.
23. Sun XY, Takagishi Y, Okabe E, Chishima Y, Kanou Y, et al. (2009) A novel Caspr mutation causes the shambling mouse phenotype by disrupting axoglial interactions of myelinated nerves. J Neuropathol Exp Neurol 68: 1207-1218.
24. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, et al. (2002) beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 31: 111-115.
25. Gascard P, Parra MK, Zhao Z, Calinisan VR, Nunomura W, et al. (2004) Putative tumor suppressor protein 4.1B is differentially expressed in kidney and brain via alternative promoters and 5′ alternative splicing. Biochim Biophys Acta 1680: 71-82.
26. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493-506.
27. Yang Y, Lacas-Gervais S, Morest DK, Solimena M, Rasband MN, (2004) BetaIV spectrins are essential for membrane stability and the molecular organization of nodes of Ranvier. J Neurosci 24: 7230-7240.
28. Peles E, Nativ M, Lustig M, Grumet M, Schilling J, et al. (1997) Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J 16: 978-988.
29. Charles P, Tait S, Faivre-Sarrailh C, Barbin G, Gunn-Moore F, et al. (2002) Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction. Curr Biol 12: 217-220.
30. Gollan L, Salomon D, Salzer JL, Peles E, (2003) Caspr regulates the processing of contactin and inhibits its binding to neurofascin. J Cell Biol 163: 1213-1218.
31. Bonnon C, Bel C, Goutebroze L, Maigret B, Girault JA, et al. (2007) PGY repeats and N-glycans govern the trafficking of paranodin and its selective association with contactin and neurofascin-155. Mol Biol Cell 18: 229-241.
32. Poliak S, Salomon D, Elhanany H, Sabanay H, Kiernan B, et al. (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162: 1149-1160.
33. Friede RL, (1983) Variance in relative internode length (l/d) in the rat and its presumed significance for the safety factor and neuropathy. J Neurol Sci 60: 89-104.
34. Fannon AM, Sherman DL, Ilyina-Gragerova G, Brophy PJ, Friedrich VL Jr, et al. (1995) Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J Cell Biol 129: 189-202.
35. Chang BJ, Cho IJ, Brophy PJ, (2000) A study on the immunocytochemical localization of neurofascin in rat sciatic nerve. J Vet Sci 1: 67-71.
36. Zhou L, Zhang CL, Messing A, Chiu SY, (1998) Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. J Neurosci 18: 7200-7215.
37. Zhou Z, Vorperian VR, Gong Q, Zhang S, January CT, (1999) Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole. J Cardiovasc Electrophysiol 10: 836-843.
38. Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, et al. (2001) Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron 30: 369-383.
39. Boyle ME, Berglund EO, Murai KK, Weber L, Peles E, et al. (2001) Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 30: 385-397.
40. Yi C, McCarty JH, Troutman SA, Eckman MS, Bronson RT, et al. (2005) Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer. Mol Cell Biol 25: 10052-10059.
41. Wang H, Kunkel DD, Martin TM, Schwartzkroin PA, Tempel BL, (1993) Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons. Nature 365: 75-79.
42. Horresh I, Poliak S, Grant S, Bredt D, Rasband MN, et al. (2008) Multiple molecular interactions determine the clustering of Caspr2 and Kv1 channels in myelinated axons. J Neurosci 28: 14213-14222.
43. Ogawa Y, Oses-Prieto J, Kim MY, Horresh I, Peles E, et al. (2010) ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons. J Neurosci 30: 1038-1048.
44. Vabnick I, Trimmer JS, Schwarz TL, Levinson SR, Risal D, et al. (1999) Dynamic potassium channel distributions during axonal development prevent aberrant firing patterns. J Neurosci 19: 747-758.
45. Devaux J, Gola M, Jacquet G, Crest M, (2002) Effects of K+ channel blockers on developing rat myelinated CNS axons: identification of four types of K+ channels. J Neurophysiol 87: 1376-1385.
46. Devaux JJ, Kleopa KA, Cooper EC, Scherer SS, (2004) KCNQ2 is a nodal K+ channel. J Neurosci 24: 1236-1244.
47. Langley RC Jr, Cohen CM, (1987) Cell type-specific association between two types of spectrin and two types of intermediate filaments. Cell Motil Cytoskeleton 8: 165-173.
48. Frappier T, Stetzkowski-Marden F, Pradel LA, (1991) Interaction domains of neurofilament light chain and brain spectrin. Biochem J 275: 521-527.
49. Macioce P, Gandolfi N, Leung CL, Chin SS, Malchiodi-Albedi F, et al. (1999) Characterization of NF-L and betaIISigma1-spectrin interaction in live cells. Exp Cell Res 250: 142-154.
50. Julien JP, (1999) Neurofilament functions in health and disease. Curr Opin Neurobiol 9: 554-560.
51. Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, et al. (2002) Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res 62: 5129-5133.
52. Maurel P, Einheber S, Galinska J, Thaker P, Lam I, et al. (2007) Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination. J Cell Biol 178: 861-874.
53. Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, et al. (2007) A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination. Nat Neurosci 10: 861-869.
54. Leneuve P, Colnot S, Hamard G, Francis F, Niwa-Kawakita M, et al. (2003) Cre-mediated germline mosaicism: a new transgenic mouse for the selective removal of residual markers from tri-lox conditional alleles. Nucleic Acids Res 31: e21.
55. Menegoz M, Gaspar P, Le Bert M, Galvez T, Burgaya F, et al. (1997) Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 19: 319-331.
56. Denisenko N, Cifuentes-Diaz C, Irinopoulou T, Carnaud M, Benoit E, et al. (2008) Tumor suppressor schwannomin/merlin is critical for the organization of Schwann cell contacts in peripheral nerves. J Neurosci 28: 10472-10481.
57. Zonta B, Tait S, Melrose S, Anderson H, Harroch S, et al. (2008) Glial and neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system. J Cell Biol 181: 1169-1177.
58. Yoshimura K, Negishi T, Kaneko A, Sakamoto Y, Kitamura K, et al. (1996) Monoclonal antibodies specific to the integral membrane protein P0 of bovine peripheral nerve myelin. Neurosci Res 25: 41-49.
59. Goutebroze L, Carnaud M, Denisenko N, Boutterin MC, Girault JA, (2003) Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes. BMC Neurosci 4: 29.
60. Cifuentes-Diaz C, Nicole S, Velasco ME, Borra-Cebrian C, Panozzo C, et al. (2002) Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum Mol Genet 11: 1439-1447.
61. Lonigro A, Devaux JJ, (2009) Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain 132: 260-273.
62. Devaux JJ, (2010) The C-terminal domain of ssIV-spectrin is crucial for KCNQ2 aggregation and excitability at nodes of Ranvier. J Physiol 588: 4719-4730.
63. de Medinaceli L, Freed WJ, Wyatt RJ, (1982) An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp Neurol 77: 634-643.
64. Ozmen S, Ayhan S, Latifoglu O, Siemionow M, (2002) Stamp and paper method: a superior technique for the walking track analysis. Plast Reconstr Surg 109: 1760-1761.
65. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, et al. (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12: 1599-1609.